Clinical Trial Update: Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

View source ↗

Summary

The document reports on the impact of hybrid coronary revascularization on antiplatelet therapy in patients with Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Aarhus University Hospital Skejby | Conditions: Coronary Artery Disease | Status: COMPLETED